Search Results
134 results
Your search is now limited to «Clinical Trials» expert search.
04/23/2019 07:48
STAINES-UPON-THAMES, United Kingdom, April 23, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today confirmed it has completed enrollment in the company's Phase 4 clinical study assessing the efficacy and safety of Acthar® Gel in Systemic Lupus Erythematosus (lupus, SLE) patients with persistently active disease.
More from :
PR Newswire 04/23/2019 06:45
Dr. Anca Askanase , the Director of the Columbia University Lupus Center and Principal Investigator for this Phase 4 study, said: "I am delighted that enrollment is completed, and look forward to evaluating the data as it becomes available.
More from PR Newswire: 04/18/2019 09:16
Each volunteer will be in the study for approximately 3 months from screening to their last scheduled clinic visit.
More from
Arthritis Research & Therapy 04/17/2019 20:00
First, for PCV-13, there is only one other study evaluating responses in those using JAK inhibitors, although it is a study of patients with psoriasis.
More from Arthritis Research & Therapy:
Healio News 04/17/2019 17:04
Monoclonal antibody demonstrates ‘unprecedented’ virologic suppression in HIV study.
More from Healio News:
GlobeNewswire 04/17/2019 16:05
Information about the Company’s clinical trials can be found at the NIH registry,
More from GlobeNewswire:
FierceMedicalDevices 04/15/2019 08:07
EIP began a phase 2a trial in Alzheimer’s in 2015 before moving into phase 2b and raising $20.5 million on the strength of the resulting data.
More from FierceMedicalDevices:
BioNewsFeeds 04/12/2019 18:22
... with the investigational vaccine IFN-alpha Kinoid increased the number of systemic lupus erythematosus (SLE) patients achieving low disease activity, lessened their use of corticosteroids, and was well-tolerated, according to full results of a Phase 2b trial.
More from BioNewsFeeds:
Janssen's HIV drug SYMTUZA yields positive results in DIAMOND trial.
More from Pharmaceutical Business Review:
Business Wire 04/10/2019 07:07
The Company's lead drug candidate, Piclidenoson, is currently in Phase III trials for rheumatoid arthritis and psoriasis.
More from Business Wire:
Benzinga 04/02/2019 13:00
Key highlights from the clinical data presentation include: In this safety study, two doses of DV281 monotherapy followed by combination with nivolumab was well tolerated.
More from Benzinga:
These findings warrant further evaluation in a phase 2 study as a single agent or in combination with other approaches.
More from Middle East North Africa Financial Network (MENAFN):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications